Literature DB >> 29618581

Causes and Predictors of 30-Day Readmission in Patients With Acute Myocardial Infarction and Cardiogenic Shock.

Mahek Shah1, Shantanu Patil2, Brijesh Patel2, Manyoo Agarwal2, Carlos D Davila2, Lohit Garg2, Sahil Agrawal2, Navin K Kapur2, Ulrich P Jorde2.   

Abstract

BACKGROUND: Acute myocardial infarction (AMI) occurs as a result of irreversible damage to cardiac myocytes secondary to lack of blood supply. Cardiogenic shock complicating AMI has significant associated morbidity and mortality, and data on postdischarge outcomes are limited. METHODS AND
RESULTS: We derived the study cohort of patients with AMI and cardiogenic shock from the 2013 to 2014 Healthcare Cost and Utilization Project National Readmission Database. Incidence, predictors, and causes of 30-day readmissions were analyzed. From 43 212 index admissions for AMI with cardiogenic shock, 26 016 (60.2%) survived to discharge and 5277 (20.2% of survivors) patients were readmitted within 30 days. More than 50% of these readmissions occurred within first 10 days. Cardiac causes accounted for 42% of 30-day readmissions (heart failure 20.6%; acute coronary syndrome 11.6%). Among noncardiac causes, respiratory (11.4%), infectious (9.4%), medical or surgical care complications (6.3%), gastrointestinal/hepatobiliary (6.5%), and renal causes (4.8%) were most common. Length of stay ≥8 days (odds ratio [OR], 2.04; 95% confidence interval [CI], 1.70-2.44; P<0.01), acute deep venous thrombosis (OR, 1.26; 95% CI, 1.08-1.48; P<0.01), liver disease (OR, 1.25; 95% CI, 1.03-1.50; P=0.02), systemic thromboembolism (OR, 1.21; 95% CI, 1.02-1.44; P=0.02), peripheral vascular disease (OR, 1.16; 95% CI, 1.07-1.27; P<0.01), diabetes mellitus (OR, 1.16; 95% CI, 1.08-1.24; P<0.01), long-term ventricular assist device implantation (OR, 1.77; 95% CI, 1.23-2.55; P<0.01), intraaortic balloon pump use (OR, 1.10; 95% CI, 1.02-1.18; P<0.01), performance of coronary artery bypass grafting (OR, 0.85; 95% CI, 0.77-0.93; P<0.01), private insurance (OR, 0.72; 95% CI, 0.64-0.80; P<0.01), and discharge to home (OR, 0.85; 95% CI, 0.73-0.98; P=0.03) were among the independent predictors of 30-day readmission.
CONCLUSIONS: In-hospital mortality and 30-day readmission in cardiogenic shock complicating AMI are significantly elevated. Patients are readmitted mainly for noncardiac causes. Identification of high-risk factors may guide interventions to improve outcomes within this population.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  heart failure; mortality; myocardial infarction; readmission; shock, cardiogenic

Mesh:

Year:  2018        PMID: 29618581     DOI: 10.1161/CIRCHEARTFAILURE.117.004310

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  18 in total

1.  National trends in hospitalizations and outcomes in patients with alcoholic cardiomyopathy.

Authors:  Pradhum Ram; Kevin B Lo; Mahek Shah; Brijesh Patel; Janani Rangaswami; Vincent M Figueredo
Journal:  Clin Cardiol       Date:  2018-11-19       Impact factor: 2.882

2.  The impact of comorbid severe mental illness and common chronic physical health conditions on hospitalisation: A systematic review and meta-analysis.

Authors:  Naomi Launders; Kate Dotsikas; Louise Marston; Gabriele Price; David P J Osborn; Joseph F Hayes
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

3.  Causes, risk factors, and costs associated with ninety-day readmissions following primary total hip arthroplasty for femoral neck fractures.

Authors:  Puneet Gupta; Ivan J Golub; Aaron A Lam; Keith B Diamond; Rushabh M Vakharia; Kevin K Kang
Journal:  J Clin Orthop Trauma       Date:  2021-08-19

Review 4.  Readmission After ACS: Burden, Epidemiology, and Mitigation.

Authors:  Peter K Boulos; John C Messenger; Stephen W Waldo
Journal:  Curr Cardiol Rep       Date:  2022-04-30       Impact factor: 3.955

5.  Etiologies, predictors, and economic impact of readmission within 1 month among patients with takotsubo cardiomyopathy.

Authors:  Mahek Shah; Pradhum Ram; Kevin Bryan U Lo; Natee Sirinvaravong; Brijesh Patel; Byomesh Tripathi; Shantanu Patil; Vincent M Figueredo
Journal:  Clin Cardiol       Date:  2018-07-20       Impact factor: 2.882

6.  Mortality in sepsis: Comparison of outcomes between patients with demand ischemia, acute myocardial infarction, and neither demand ischemia nor acute myocardial infarction.

Authors:  Mahek Shah; Soumya Patnaik; Obiora Maludum; Brijesh Patel; Byomesh Tripathi; Manyoo Agarwal; Lohit Garg; Sahil Agrawal; Ulrich P Jorde; Matthew W Martinez
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

7.  Palliative Care Services in Patients Admitted With Cardiogenic Shock in the United States: Frequency and Predictors of 30-Day Readmission.

Authors:  Zekun Feng; Gregg C Fonarow; Boback Ziaeian
Journal:  J Card Fail       Date:  2021-05       Impact factor: 5.712

8.  Use of Post-Acute Care Services and Readmissions After Acute Myocardial Infarction Complicated by Cardiac Arrest and Cardiogenic Shock.

Authors:  Saraschandra Vallabhajosyula; Stephanie R Payne; Jacob C Jentzer; Lindsey R Sangaralingham; Kianoush Kashani; Nilay D Shah; Abhiram Prasad; Shannon M Dunlay
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-02-08

9.  Icariside II ameliorates myocardial ischemia and reperfusion injury by attenuating inflammation and apoptosis through the regulation of the PI3K/AKT signaling pathway.

Authors:  Bing-Feng Guan; Xiao-Feng Dai; Qi-Bin Huang; Di Zhao; Jin-Long Shi; Cheng Chen; Yan Zhu; Fen Ai
Journal:  Mol Med Rep       Date:  2020-07-31       Impact factor: 2.952

10.  A Quality Improvement Approach to Reduce 30-day Readmissions and Mortality in Patients with Acute Decompensated Heart Failure.

Authors:  Yee Yin Hoo; Wardati Mazlan-Kepli; Wan Nurul Huda Wan Hasan; Fan Jie Chen; Prashanthini Devadas; Yan Yee Chow; Qian Yi Sow; Azrol Amar Azizan; Abdul Muizz Abd Malek; Glendon Seng Kiong Lau; Ping Lik Chua
Journal:  J Saudi Heart Assoc       Date:  2020-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.